Viral Neutralization Assay

Theory

When a virus infects a host, the immune system responds by producing antibodies against viral antigens. Among these, a specific group known as neutralizing antibodies plays a critical role in protection. These antibodies bind to viral surface proteins that are essential for entry into host cells, thereby blocking infection.

Unlike binding antibodies that may attach to the virus without preventing infection, neutralizing antibodies directly interfere with viral attachment, fusion, or entry into the host cell. This functional property makes them an important indicator of protective immunity.

In a laboratory setting, this concept is applied by mixing a virus with serum samples that may contain neutralizing antibodies. If such antibodies are present, they will bind to the virus and prevent it from infecting cultured cells. If they are absent or insufficient, the virus will infect the cells and produce visible structural damage known as the "cytopathic effect" (CPE).

Virus neutralization assays are widely used in virology and immunology, particularly in vaccine studies, sero-surveillance, and evaluation of immune responses following infection.

Principle

The virus neutralization assay is based on the principle that neutralizing antibodies can inhibit viral infectivity in host cells.

A fixed quantity of virus is incubated with serial dilutions of the test serum. During this incubation, if neutralizing antibodies are present, they form antigen–antibody complexes with the virus. This interaction prevents the virus from entering and replicating inside host cells.

The mixture is then added to a monolayer of susceptible cells. After incubation, the cells are observed microscopically. If the virus has been neutralized, the cells remain healthy and intact. If not, viral replication leads to cell damage, which appears as cytopathic effects such as rounding, detachment, or lysis.

The highest dilution of serum that still prevents visible cytopathic effect is taken as the neutralization titer, which reflects the strength of the antibody response.